Few studies were done to determine belly fat in adults which increases heart disease, diabetes and stroke. Researchers say waist to hip ratio indicates the health of an adult. It should be less than 1.0 for an adult. Kids are at risk if the indicator is more than 0.9. Dr. Fals (Pediatrician at Florida Hospital for Children) and researcher Lindy Moore (Exercise Physiology Manager) are studying a non-invasive way to accurately predict a child's diabetes risk.
Researchers found a hormone that can treat type 2 diabetes (T2D). Researchers are from Norwegian University of Science and Technology (NTNU) and Oxford University. Researchers say gastric bypass surgery is the most effective treatment for the weight loss. After the surgery, sugar levels were reduced and shown marked improvements in other diabetes parameters. Researchers believed remission of type 2 diabetes after Gastric bypass surgery is due to increase in the production of the GLP-1 hormone that reduces appetite. But the researchers while experimenting with rats found another hormone, PYY that reduces appetite. With these findings, researchers are thinking of stimulating hormones to control appetite and control type 2 diabetes (T2D).
National Microbiome Initiative (NMI) programme was launched by the White House to conduct research that can answer questions about microbiomes. Healthy microbiomes help process industries and also in maintaining ecological balance, agricultural production and keeping us healthy. The Bill and Melinda Gates Foundation is spending on the studies of human and agricultural microbiomes. Juvenile Diabetes Research Foundation also spending to study the relation between microbiomes and type 1 diabetes (T1D).
A free booklet for schools was being distributed by InDependent Diabetes Trust (IDDT), an international charity based in Northampton. The pdf booklet contains information and tips about diabetes to educate students.
Damien Keating (professor at Flinders University in Australia) and his team, while studying genes of persons with down syndrome, found a single gene, called RCAN1. This RCAN1 may be playing a lead role in the development of type ii diabetes (and also down syndrome) by causing defects in insulin secretion. Current drugs for the treatment of diabetes are focusing on managing disease and not on the causes of the disease, like RCAN1 gene. Scientists say no one knows which changes pancreas into type 2 diabetes (T2D). Type 2 diabetes (T2D) is a complex metabolic disease caused because of beta-cell dysfunction. The research finding was published in the journal PLOS Genetics.
Tandem Diabetes Care, Inc. is a medical devices company, manufactures and sells products for insulin dependent diabetes people. Insulin pump products are slim Insulin Delivery System, flex Insulin Delivery System and slim G4 Insulin Delivery System. The company uses Micro-Delivery Technology which draws insulin from a flexible bag within the pump.
Institute of Diabetes Research published its first Fr1da study in BMJ Open journal. Started in Feb 2015, Fr1da is a study of the early detection of type 1 diabetes (T1D) by examination of pancreatic beta cell autoantibodies in blood. Bavarian pilot project Fr1da study can help in finding treatment for the diabetic ketoacidosis (DKA). DKA is the condition with high blood glucose levels and lack of insulin in our body. When such thing happens, there will be a breakdown in our fat for energy and deposits of ketones in the blood and urine. If one finds type 1 diabetes (T1D) early and if it is asymptomatic, then there is a possibility of reducing life-threatening metabolic imbalance (ketoacidosis).
The Diabetes News Chronicle does not provide medical advice, diagnosis or treatment. Information in Diabetes News Chronicle is to support and not to replace medical advice given by the surgeon or physician or doctor. Published article is not a medical advice by the OWNER of "Diabetes News Chronicle" website or by the AUTHOR of the article.
Published by Jammi Vasista, Chennai, India.